Accessibility Menu
Exagen Stock Quote

Exagen (NASDAQ: XGN)

$11.75
(0.5%)
+0.06
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$11.75
Daily Change
(0.5%) +$0.06
Day's Range
$11.58 - $11.75
Previous Close
$11.75
Open
$11.72
Beta
1.03
Volume
244,749
Average Volume
295,414
Market Cap
257.2M
Market Cap / Employee
$11.69M
52wk Range
$2.38 - $11.99
Revenue
-
Gross Margin
0.59%
Dividend Yield
N/A
EPS
-$0.89
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Exagen Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
XGN+315.19%-19.52%-4.25%-37%
S&P+15.06%+95.03%+14.29%+124%

Exagen Company Info

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$17.20M14.2%
Gross Profit$10.40M14.8%
Gross Margin60.43%0.3%
Market Cap$152.59M382.6%
Market Cap / Employee$0.73M0.0%
Employees20916.8%
Net Income-$4.44M-49.7%
EBITDA-$2.16M-0.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$30.03M22.7%
Accounts Receivable$14.27M22.0%
Inventory3.730.3%

Liabilities

Q2 2025YOY Change
Long Term Debt$23.38M6.0%
Short Term Debt$1.83M0.4%

Ratios

Q2 2025YOY Change
Return On Assets-31.42%-0.9%
Return On Invested Capital-42.32%-3.4%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$3.09M-20.8%
Operating Free Cash Flow-$2.89M-18.9%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book4.215.586.6419.571141.13%
Price to Sales1.011.361.172.50328.22%
Price to Tangible Book Value4.215.586.6419.571141.13%
Enterprise Value to EBITDA-13.66-25.90-26.96-65.78337.02%
Return on Equity-83.9%-93.8%-117.5%-87.9%25.67%
Total Debt$23.55M$23.36M$23.44M$25.20M5.56%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.